Sign in
Explore the registryTrack Tucatinib's trials

HER2CLIMB-05

A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer

TucatinibOngoingActive not recruitingPhase 3Open NCT05132582 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…